Location History:
- Augusta, GA (US) (2017)
- Evans, GA (US) (2022)
Company Filing History:
Years Active: 2017-2022
Title: Rafik Abdelsayed: Innovator in Wound Healing and Sjögren's Syndrome Treatment
Introduction
Rafik Abdelsayed is a notable inventor based in Augusta, GA (US). He has made significant contributions to the fields of wound healing and autoimmune disease treatment. With a total of 2 patents, his work focuses on innovative solutions that address critical health challenges.
Latest Patents
Abdelsayed's latest patents include formulations for wound healing that utilize glucocorticoid-induced leucine zipper protein (GILZ) peptide compositions. These compositions are designed for topical administration to wounds, available in forms such as creams, ointments, or lotions. They are effective in treating acute wounds, promoting healing in chronic wounds, and minimizing scar formation. Additionally, he has developed methods for diagnosing and treating Sjögren's Syndrome. This patent outlines techniques for detecting the disease, assessing its progression, and evaluating treatment effectiveness through the measurement of specific biomarkers in biological samples.
Career Highlights
Rafik Abdelsayed is affiliated with the Augusta University Research Institute, Inc., where he conducts his research and development. His work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative therapies.
Collaborations
Abdelsayed collaborates with esteemed colleagues, including Mahmood Mozaffari and Babak Baban, to further enhance the impact of his research.
Conclusion
Rafik Abdelsayed's contributions to wound healing and Sjögren's Syndrome treatment exemplify the importance of innovation in healthcare. His patents reflect a dedication to improving the quality of life for patients facing these medical challenges.